JP Morgan Private Wealth Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-13,276
Closed -$254K – 1964
2022
Q2
$254K Buy
13,276
+836
+7% +$15.8K ﹤0.01% 1733
2022
Q1
$248K Buy
+12,440
New +$251K ﹤0.01% 1834

Other funds holding PAHC

JP Morgan Private Wealth Advisors's PAHC Position: Q3 2022 in Review

JP Morgan Private Wealth Advisors sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 13,276 shares — an estimated $254K sold.

JP Morgan Private Wealth Advisors first reported a position in PAHC in Q1 2022 and held it in 2 quarters. The position peaked at $254K in Q2 2022. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 13,276 Phibro Animal Health shares in Q3 2022, an estimated $254K.
  • JP Morgan Private Wealth Advisors first reported a position in Phibro Animal Health in Q1 2022 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Phibro Animal Health position peaked at $254K in Q2 2022.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.